<unk>  is considered an indication for re-biopsy; in one survey of urologists 98% of respondents considered it a sufficient reason to re-biopsy.
Atypical small acinar proliferation
Nodular regenerative hyperplasia
In situ lymphoid neoplasia
Pancreatic acinar metaplasia
Intranodal palisaded myofibroblastoma
Perifollicular mucinosis
Microglandular hyperplasia
Folliculosebaceous cystic hamartoma